跳至主要内容
临床试验/NCT01444573
NCT01444573Unknown3 期

Rate Ventricular Control Therapy by Implantable Continuous Monitor in Patients With Permanent Atrial Fibrillation

Meshalkin Research Institute of Pathology of Circulation2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2011年9月1日最近更新:
适应症

试验速览

阶段
3 期
发起方
入组人数
90
试验地点
2
主要终点
Hospitalization for all cardio-vascular events

研究概览

简要总结

The investigators hypothesized that very lenient rate control is not inferior to strict or lenient rate control assessed by implantable continuous ECG monitor for preventing cardiovascular hospitalization and mortality in patients with long-standing persistent or permanent atrial fibrillation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Long-standing persistent or permanent atrial fibrillation
  • Mean resting heart rate > 80 beats per minute with or without rate control medication
  • Age < 70 years old
  • Constant use of anticoagulation therapy

排除标准

  • Paroxysmal or persistent atrial fibrillation
  • Non-stable heart failure or > III NYHA FC
  • Indications for IPG/CRT/ICD
  • Thyroid dysfunction
  • Inability to walk or bike.

结局指标

主要结局

Hospitalization for all cardio-vascular events

时间窗: 12 months

次要结局

  • All-cause death(12 months)
  • stroke(12 months)
  • life-threatening arrhythmic and drugs adverse events(12 months)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验